Brain Health Support Program
Key facts
- Who runs it
- Baycrest
- Where
- Canada7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 354 people enrolled
- Started
- 6 Apr 2022
- Ended
- 19 Apr 2024
- Type of study
- Interventional
- Treatments tested
- Brain Health PRO
- Record updated
- 2 May 2025
Who can take part
- Age
- 60 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Completion and documentation of the electronic Informed Consent Process (from the participant)
- Sufficient proficiency in English or French to undergo remote clinical and neuropsychological assessment and participate in an online educational program
- Technical ability to participate in an online educational program and remote assessments (i.e. computer and internet access; ability to send and receive emails; ability to complete remote assessments)
- Sufficient vision and hearing to participate in online educational program and to undergo remote clinical and neuropsychological testing
- Ability to sit comfortably for a period of about 30 minutes
- Ages 60-85
- Meets criteria for No Dementia and meet criteria [according to Canadian Consortium on Neurodegeneration in Aging (CCNA) Criteria, Appendix 1] of one of the following:; Cognitively Unimpaired (CU); Cognitively Unimpaired plus Subjective Cognitive Impairment (CU + SCI); Mild Cognitive Impairment (MCI)
- AND Classified as being at increased risk of dementia based on at least one of the following:; First-degree family history of dementia; Self-Reported or documented current and/or history at midlife (45-60 years) on any of the following lifestyle risk factors:; Hypertension (documented Systolic Blood Pressure > 140 mm Hg; OR physician diagnosis of hypertension; OR treatment for hypertension; OR other approaches to treatment (e.g. diet, exercise)) Hypercholesterolemia (documented total cholesterol > 6.5 mmol/L; OR physician diagnosis of hypercholesterolemia; OR treatment for hypercholesterolemia; OR other approaches to treatment (e.g. diet, exercise) Body Mass Index > 30 kg/m2 (derived from NIH Metric BMI Calculator) Physical Inactivity (active is defined as engaging in a minimum of 20- 30 min of physical activity causing sweating and breathlessness, at least 2 times a week)
- Participant has a family physician or other healthcare provider and agrees to have the provider notified of participation in the study and incidental or other findings that may be clinically significant
Who cannot take part
- Individuals who have a clinical diagnosis of Dementia
- Clinical Dementia Rating (CDR; telephone/video-conference administration) Score of >1
- Participants who, in the opinion of the investigator, are not able to complete trial procedures remotely or adhere to the schedule of study assessments will be excluded from study participation
- Individuals where English or French is not sufficiently proficient for remote clinical assessment, neuropsychological testing and participation in an online educational program
- Participants who do not have sufficient vision and hearing for remote clinical assessment, neuropsychological testing participation in an online educational program
- Individuals who do not have the technical ability to participate in an online educational program. Technical ability is defined as having computer and internet access; ability to send and receive emails; ability to participate in remote assessments
- Total Score on the Montreal Cognitive Assessment (MoCA; video-conference administration) <13
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP, or CTU) is a comprehensive and innovative program aimed to develop, implement and evaluate an interactive and compelling online educational Brain Health Support Program (BHSP) intervention, called Brain Health PRO (BHPro), with potential to positively influence dementia literacy, lifestyle risk factors, and scale-up to reach the broader Canadian public; enroll and retain a community-dwelling Platform Trial Cohort (PTC) of individuals at risk of dementia; and support an open platform trial to test a variety of multidomain interventions that might further benefit individuals at risk of dementia.
The group in the trial
- Brain Health PROOther group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia: Brain Health Support Program Intervention
- Publications
- Brain health PRO/Santé cerveau PRO: The development of a web-based program for dementia literacy and risk factor reduction.The journal of prevention of Alzheimer's disease, 2025
- Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention Study.The journal of prevention of Alzheimer's disease, 2023
- Record updated
- 2 May 2025